Skin Diseases Clinical Trials

15 recruiting

Skin Diseases Trials at a Glance

18 actively recruiting trials for skin diseases are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Chicago, München, and Berlin. Lead sponsors running skin diseases studies include C5 Biomedical, Centre for Human Drug Research, Netherlands, and BeOne Medicines.

Browse skin diseases trials by phase

Treatments under study

About Skin Diseases Clinical Trials

Looking for clinical trials for Skin Diseases? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Skin Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Skin Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting
Early Phase 1

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

Skin Diseases
Northwestern University30 enrolled1 locationNCT05649098
Recruiting
Phase 3

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

AlopeciaSkin DiseasesAreata Alopecia+3 more
Eli Lilly and Company595 enrolled127 locationsNCT05723198
Recruiting
Phase 2

Effects of Treatments on Atopic Dermatitis

DermatitisEczemaSkin Diseases, Genetic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)130 enrolled1 locationNCT01631617
Recruiting
Phase 1

A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases

Skin Diseases
BeOne Medicines98 enrolled1 locationNCT07412691
Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Skin DiseasesAutoimmune Bullous DermatosisDysimmune Dermatological Diseases+1 more
University Hospital, Toulouse800 enrolled1 locationNCT06387654
Recruiting
Phase 2

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Pyoderma GangrenosumWound HealSkin Diseases+2 more
Oregon Health and Science University17 enrolled2 locationsNCT06563323
Recruiting

Deep Phenotyping of CIndU

Skin DiseasesAngio-Oedema and/or Urticaria
Centre for Human Drug Research, Netherlands40 enrolled3 locationsNCT07359430
Recruiting
Phase 3

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Skin DiseasesEpidermolysis BullosaConnective Tissue Disease+7 more
Chiesi Farmaceutici S.p.A.6 enrolled6 locationsNCT06917690
Recruiting
Not Applicable

OCT Vibrography for Biomechanical Properties of Tissues

Skin DiseasesCorneaGingival Diseases
Massachusetts General Hospital90 enrolled1 locationNCT05759780
Recruiting

Skin Reactions Related to Thoracic Implantable Chamber Dressings

Skin Diseases
Institut Curie500 enrolled3 locationsNCT07158879
Recruiting

An Observational Study to Assess Objective Skin Pigmentation Variation.

Skin DiseasesHealthy Skin
Leiden University Medical Center600 enrolled1 locationNCT07091604
Recruiting

Multi-modal Quantitative Imaging of the Skin

Skin CancerPeripheral Arterial DiseaseAtopic Dermatitis+4 more
HJN Sverige AB/Neko Health8,000 enrolled3 locationsNCT06989216
Recruiting

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

BCCBCC - Basal Cell CarcinomaEyelid Tumor+2 more
Vejle Hospital210 enrolled1 locationNCT06279143
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

OsteomyelitisEncephalitisSepsis+13 more
Infectopharm Arzneimittel GmbH1,000 enrolled50 locationsNCT02979951
Recruiting
Phase 2

Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?

Skin DiseasesHyperhidrosisOxybutynin+4 more
Samantha Rodrigues Camargo Neves de Moura17 enrolled1 locationNCT05102396
Recruiting
Not Applicable

Digital Toolkit for Skin Diseases in LMICs: Part 2

Skin Diseases
Tulane University1,000 enrolled1 locationNCT06292260